These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril. Dinicolantonio JJ; Lavie CJ; O'Keefe JH Postgrad Med; 2013 Jul; 125(4):154-68. PubMed ID: 23933903 [TBL] [Abstract][Full Text] [Related]
5. The EUROPA trial. Boos C Lancet; 2003 Dec; 362(9399):1935; author reply 1936-7. PubMed ID: 14667756 [No Abstract] [Full Text] [Related]
6. [Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information]. Nilsson PM Lakartidningen; 2007 Oct 17-23; 104(42):3028-9. PubMed ID: 17985709 [No Abstract] [Full Text] [Related]
7. Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors? White HD Lancet; 2003 Sep; 362(9386):755-7. PubMed ID: 13678865 [No Abstract] [Full Text] [Related]
8. [Clinical study of the month. The HOPE study, a two-by-two factorial clinical trial with contrasted results]. Scheen AJ Rev Med Liege; 2000 Feb; 55(2):121-4. PubMed ID: 10769584 [TBL] [Abstract][Full Text] [Related]
9. A population-based study of the drug interaction between clopidogrel and angiotensin converting enzyme inhibitors. Cressman AM; Macdonald EM; Fernandes KA; Gomes T; Paterson JM; Mamdani MM; Juurlink DN; Br J Clin Pharmacol; 2015 Oct; 80(4):662-9. PubMed ID: 25980448 [TBL] [Abstract][Full Text] [Related]
10. Combine EUROPA and HOPE. Fuller JA Lancet; 2003 Dec; 362(9399):1937. PubMed ID: 14667761 [No Abstract] [Full Text] [Related]
12. Ramipril in the treatment of vascular diseases. Rokoss MJ; Teo KK Expert Opin Pharmacother; 2005 Sep; 6(11):1911-9. PubMed ID: 16144510 [TBL] [Abstract][Full Text] [Related]
13. Angiotensin-converting enzyme inhibition in cardiovascular disease: evidence with perindopril. Ferrari R Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):15-29. PubMed ID: 15723572 [TBL] [Abstract][Full Text] [Related]
14. HOPE for all people with diabetes? Heart Outcomes Prevention Evaluation. Marshall SM Diabet Med; 2000 Sep; 17 Suppl 2():9-10. PubMed ID: 11048826 [No Abstract] [Full Text] [Related]
15. [Results of ADVANCE trial conducted in type 2 diabetic patients]. Ter Arkh; 2008; 80(1):88. PubMed ID: 18326237 [No Abstract] [Full Text] [Related]
16. Telmisartan versus angiotension-converting enzyme inhibitors in the treatment of hypertension: a meta-analysis of randomized controlled trials. Zou Z; Xi GL; Yuan HB; Zhu QF; Shi XY J Hum Hypertens; 2009 May; 23(5):339-49. PubMed ID: 18987649 [TBL] [Abstract][Full Text] [Related]
17. [In the framework of the 72nd Annual Meeting of the DKG (German CardiologySociety) in Mannheim presented: Ontarget-the until now largest study program on cardiovascular prevention in patients with hypertension]. MMW Fortschr Med; 2006 Jun; 148(26):50-1. PubMed ID: 16875381 [No Abstract] [Full Text] [Related]
18. Cardiovascular protection with ace inhibitors--more HOPE for EUROPA? Boos CJ Med Sci Monit; 2004 Dec; 10(12):SR23-8. PubMed ID: 15567997 [TBL] [Abstract][Full Text] [Related]